PC-CA125 - Primary Care Cancer Antigen 125
In collaboration with Oxford University Hospitals Trust we are undertaking a large analysis of linked data to examine trends of CA125 use in primary care for suspected ovarian cancer, subsequent testing in secondary care, and the final outcomes in patients who have been tested. Our findings will inform national guidance on the use of CA125 in primary care.